4.7 Article

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Cathepsin K inhibitors: A novel target for osteoporosis therapy

S. A. Stoch et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)

Article Endocrinology & Metabolism

Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial

Susan L. Greenspan et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)

Article Medicine, General & Internal

Denosumab in postmenopausal women with low bone mineral density

MR McClung et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Endocrinology & Metabolism

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate

NB Watts et al.

JOURNAL OF CLINICAL DENSITOMETRY (2004)

Review Medicine, General & Internal

Risedronate -: A clinical review

C Crandall

ARCHIVES OF INTERNAL MEDICINE (2001)